Sort
11,323 grants matching “glioblastoma”
Na-K-Cl cotransporter in Glioblastoma Multiforme
$327,347Dandan Sun · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · NS
Small Molecule Antibody Mimics: Toward a New Paradigm in Targeted Cancer Therapy
$327,334David Adam Spiegel · Yale University · R01 · FY2015 · GM
Using Cell-Penetrant Peptides to Target ATF5 in Mouse Glioma Models
$327,245James M Angelastro · University Of California At Davis · R01 · FY2018 · NS
The Role of MMSET in DNA damage response and Chemoradioresistance
$327,228Zhenkun Lou · Mayo Clinic Rochester · R01 · FY2010 · CA
Project 2 - Clinical translation
$327,209Robert A Gatenby · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2019 · CA
Combining Anti-Invasive and Anti-Angiogenic Therapies for the treatment of GBM
$327,207Panagiotis Z Anastasiadis · Mayo Clinic Jacksonville · R01 · FY2011 · NS
Targeting Metabolic Vulnerabilities with Molecular Inhibitors of Oxidative Phosphorylation
$327,153Florian Muller · University Of Tx Md Anderson Can Ctr · P50 · FY2020 · CA
Novel Targeted Therapeutics for Cental Nervous System Malignancies
$327,069Francis Ali-Osman · Duke University · R01 · FY2008 · CA
Enhanced Drug Delivery to Metastatic Brain Tumors
$327,038Cedars-Sinai Medical Center · R01 · FY2004 · NS
Enhanced Drug Delivery to Metastatic Brain Tumors
$327,038Cedars-Sinai Medical Center · R01 · FY2003 · NS
Defining the role of mutant IDH in glioma initiation and maintenance
$327,031Sheri L. Holmen · University Of Utah · R01 · FY2012 · NS
Using Proton MRS to Predict Response of SAHA treatment in Glioblastoma
$327,011Hyunsuk Shim · Emory University · R21 · FY2011 · CA
GENETIC NEUROCARCINOGEN RISKS & OUTCOMES FOR BRAIN TUMOR
$326,951Faith B Davis · Duke University · P50 · FY2006 · CA
Defining the role of BRAF in glioma initiation and maintenance
$326,940Sheri L. Holmen · University Of Utah · R01 · FY2012 · NS
Investigation of Notch-inhibiting microRNAs in glioma
$326,937Benjamin W. Purow · University Of Virginia · R01 · FY2009 · CA
GENETIC NEUROCARCINOGEN RISKS &OUTCOMES FOR BRAIN TUMOR
$326,912Duke University · P50 · FY2005 · CA
Predicting Transcriptional and Epigenetic Networks in Cancer from Sequencing Data
$326,848Jun S Song · University Of Illinois At Urbana-Champaign · R01 · FY2020 · CA
Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma
$326,813Michael J Eck · Dana-Farber Cancer Inst · R01 · FY2012 · CA
Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma
$326,813Michael J Eck · Dana-Farber Cancer Inst · R01 · FY2015 · CA
Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma
$326,813Michael J Eck · Dana-Farber Cancer Inst · R01 · FY2016 · CA
Genetic Modulation of Cognitive Function and outcomes in Glioblastoma Patients
$326,705Melissa L Bondy · University Of Tx Md Anderson Can Ctr · P50 · FY2010 · CA
Genetic Modulation of Cognitive Function and outcomes in Glioblastoma Patients
$326,603Melissa L Bondy · University Of Tx Md Anderson Can Ctr · P50 · FY2012 · CA
Co-targeting mTOR and YAP signaling in glioblastoma
$326,586Joseph F Gera · Greater Los Angeles Veterans Research And Education Foundation · R01 · FY2021 · CA
Role of cell cycle inhibitors in adult neural stem cells
$326,550Patrizia Casaccia · Icahn School Of Medicine At Mount Sinai · R01 · FY2008 · NS
Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma
$326,489Matthew L Meyerson · Dana-Farber Cancer Inst · R01 · FY2008 · CA